Cargando…

Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods

BACKGROUND: Replacement of radioligand binding assays with antibody-antigen interaction-based approaches for quantitative analysis of G protein-coupled receptor (GPCR) levels requires the use of purified protein standards containing the antigen. GPCRs in general and cannabinoid CB(1) receptor in par...

Descripción completa

Detalles Bibliográficos
Autores principales: Saumell-Esnaola, Miquel, Elejaga-Jimeno, Ainhoa, Echeazarra, Leyre, Borrega-Román, Leire, Barrondo, Sergio, López de Jesús, Maider, González-Burguera, Imanol, Gómez-Caballero, Alberto, Goicolea, María Aranzazu, Sallés, Joan, García del Caño, Gontzal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479267/
https://www.ncbi.nlm.nih.gov/pubmed/36109736
http://dx.doi.org/10.1186/s12934-022-01914-1
_version_ 1784790750518575104
author Saumell-Esnaola, Miquel
Elejaga-Jimeno, Ainhoa
Echeazarra, Leyre
Borrega-Román, Leire
Barrondo, Sergio
López de Jesús, Maider
González-Burguera, Imanol
Gómez-Caballero, Alberto
Goicolea, María Aranzazu
Sallés, Joan
García del Caño, Gontzal
author_facet Saumell-Esnaola, Miquel
Elejaga-Jimeno, Ainhoa
Echeazarra, Leyre
Borrega-Román, Leire
Barrondo, Sergio
López de Jesús, Maider
González-Burguera, Imanol
Gómez-Caballero, Alberto
Goicolea, María Aranzazu
Sallés, Joan
García del Caño, Gontzal
author_sort Saumell-Esnaola, Miquel
collection PubMed
description BACKGROUND: Replacement of radioligand binding assays with antibody-antigen interaction-based approaches for quantitative analysis of G protein-coupled receptor (GPCR) levels requires the use of purified protein standards containing the antigen. GPCRs in general and cannabinoid CB(1) receptor in particular show a progressive tendency to aggregate and precipitate in aqueous solution outside of their biological context due to the low solubility that the hydrophobic nature imprinted by their seven transmembrane domains. This renders full-length recombinant GPCRs useless for analytical purposes, a problem that can be overcome by engineering soluble recombinant fragments of the receptor containing the antigen. RESULTS: Here we generated highly soluble and stable recombinant protein constructs GST-CB1(414–472) and GST-CB1(414-442) containing much of the human CB(1) receptor C-terminal tail for use as standard and negative control, respectively, in quantitative Western blot analysis of CB(1) receptor expression on crude synaptosomes of the adult rat brain cortex. To this end we used three different antibodies, all raised against a peptide comprising the C-terminal residues 443–473 of the mouse CB(1) receptor that corresponds to residues 442–472 in the human homolog. Estimated values of CB(1) receptor density obtained by quantitative Western blot were of the same order of magnitude but slightly higher than values obtained by the radioligand saturation binding assay. CONCLUSIONS: Collectively, here we provide a suitable Western blot-based design as a simple, cost-effective and radioactivity-free alternative for the quantitative analysis of CB(1) receptor expression, and potentially of any GPCR, in a variety of biological samples. The discrepancies between the results obtained by quantitative Western blot and radioligand saturation binding techniques are discussed in the context of their particular theoretical bases and methodological constraints. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-022-01914-1.
format Online
Article
Text
id pubmed-9479267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94792672022-09-17 Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods Saumell-Esnaola, Miquel Elejaga-Jimeno, Ainhoa Echeazarra, Leyre Borrega-Román, Leire Barrondo, Sergio López de Jesús, Maider González-Burguera, Imanol Gómez-Caballero, Alberto Goicolea, María Aranzazu Sallés, Joan García del Caño, Gontzal Microb Cell Fact Research BACKGROUND: Replacement of radioligand binding assays with antibody-antigen interaction-based approaches for quantitative analysis of G protein-coupled receptor (GPCR) levels requires the use of purified protein standards containing the antigen. GPCRs in general and cannabinoid CB(1) receptor in particular show a progressive tendency to aggregate and precipitate in aqueous solution outside of their biological context due to the low solubility that the hydrophobic nature imprinted by their seven transmembrane domains. This renders full-length recombinant GPCRs useless for analytical purposes, a problem that can be overcome by engineering soluble recombinant fragments of the receptor containing the antigen. RESULTS: Here we generated highly soluble and stable recombinant protein constructs GST-CB1(414–472) and GST-CB1(414-442) containing much of the human CB(1) receptor C-terminal tail for use as standard and negative control, respectively, in quantitative Western blot analysis of CB(1) receptor expression on crude synaptosomes of the adult rat brain cortex. To this end we used three different antibodies, all raised against a peptide comprising the C-terminal residues 443–473 of the mouse CB(1) receptor that corresponds to residues 442–472 in the human homolog. Estimated values of CB(1) receptor density obtained by quantitative Western blot were of the same order of magnitude but slightly higher than values obtained by the radioligand saturation binding assay. CONCLUSIONS: Collectively, here we provide a suitable Western blot-based design as a simple, cost-effective and radioactivity-free alternative for the quantitative analysis of CB(1) receptor expression, and potentially of any GPCR, in a variety of biological samples. The discrepancies between the results obtained by quantitative Western blot and radioligand saturation binding techniques are discussed in the context of their particular theoretical bases and methodological constraints. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-022-01914-1. BioMed Central 2022-09-15 /pmc/articles/PMC9479267/ /pubmed/36109736 http://dx.doi.org/10.1186/s12934-022-01914-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Saumell-Esnaola, Miquel
Elejaga-Jimeno, Ainhoa
Echeazarra, Leyre
Borrega-Román, Leire
Barrondo, Sergio
López de Jesús, Maider
González-Burguera, Imanol
Gómez-Caballero, Alberto
Goicolea, María Aranzazu
Sallés, Joan
García del Caño, Gontzal
Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods
title Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods
title_full Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods
title_fullStr Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods
title_full_unstemmed Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods
title_short Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods
title_sort design and validation of recombinant protein standards for quantitative western blot analysis of cannabinoid cb(1) receptor density in cell membranes: an alternative to radioligand binding methods
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479267/
https://www.ncbi.nlm.nih.gov/pubmed/36109736
http://dx.doi.org/10.1186/s12934-022-01914-1
work_keys_str_mv AT saumellesnaolamiquel designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT elejagajimenoainhoa designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT echeazarraleyre designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT borregaromanleire designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT barrondosergio designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT lopezdejesusmaider designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT gonzalezburgueraimanol designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT gomezcaballeroalberto designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT goicoleamariaaranzazu designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT sallesjoan designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods
AT garciadelcanogontzal designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods